Assistance options and helpful resources
MARGENZA Access Support offers personalized support for patients who have been prescribed MARGENZA and their caregivers.
Call 1-844-MED-MGNX (1-844-633-6469) to connect with a support specialist who can:
- Help you or the person you care for enroll in MARGENZA Access Support
- Answer questions about the Copay Assistance and Patient Assistance Programs
- Review the eligibility guidelines for the Copay Assistance and Patient Assistance Programs
- Provide help finding assistance from foundations and charities if you do not have insurance or are not eligible for the Copay Assistance and Patient Assistance Programs
MARGENZA Access Support does not give medical advice and will direct you to your healthcare professional for any questions about your treatment.
The MARGENZA Copay Assistance Program for commercially insured eligible patients
If you have health insurance that is not provided by your state or the federal government—from a job (yours, your spouse’s, or your parent’s) or from a healthcare exchange—then you most likely have what’s called commercial insurance.
Here’s how it works: If you are left with a remaining cost after meeting your policy’s copay, the program will pay for the entirety of your remaining cost share, including coinsurance and copays for MARGENZA, up to a maximum of $26,000 during a 12-month period for eligible patients.
Don’t have commercial insurance? We offer a Patient Assistance Program and referrals to Independent Foundations.
- You have been prescribed MARGENZA.
- You have commercial insurance that covers your prescribed medicine, but your insurance does not cover the full cost; that is, you have a copay or coinsurance obligation.
- MARGENZA must be covered by your commercial insurance plan. Offer excludes full cash-paying patients. This offer may not be redeemed for cash.
- You are not participating in any state or federal healthcare program including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, Veterans Affairs (VA), CHAMPUS, Department of Defense (DoD), TRICARE®, or any state patient or pharmaceutical assistance program, or wherever prohibited by law. Patients who move from commercial insurance to a state or federal healthcare program will no longer be eligible. Patients who start utilizing their government coverage during their enrollment period will no longer be eligible for the program. Uninsured and cash-paying patients are NOT eligible for this program. Cash Discount Cards and other non-insurance plans are not valid as primary insurance under this offer. If the patient is eligible for drug benefits under any such program, the patient cannot use this offer.
- This program cannot be combined with any coupon, certificate, voucher, or similar offer.
- You are 18 years of age or older and are receiving MARGENZA for an FDA-approved use. Please ask your doctor for information about FDA-approved uses. Also see your doctor for the full US Prescribing Information for MARGENZA.
- You are a resident of the United States or Puerto Rico.
- Patient is responsible for complying with any insurance carrier copayment disclosure requirements, including disclosing any savings received from this Program. It is illegal to (or offer to) sell, purchase, or trade this offer.
Be sure to talk with your doctor about enrolling in the MARGENZA Copay Assistance Program.
If your doctor wants you to get started filling out the form, download it below and then follow the instructions on the form.
If you have questions or need help filling out the form, we’re here to help! Call 1-844-MED-MGNX (1-844-633-6469).
The MARGENZA Patient Assistance Program
Patients who meet financial eligibility and other requirements can receive a free year’s supply of MARGENZA.
Patients must meet all the requirements listed below to qualify:
- You have been prescribed MARGENZA for a medically appropriate use
- You are a permanent, legal resident of the United States, Puerto Rico, or US Virgin Islands
- You have no insurance or your insurance does not cover MARGENZA (except for Medicare beneficiaries, subject to certain restrictions)
- The treatment must be provided in an outpatient setting
- You must have received treatment within 180 days of application approval
- Your Annual Household Income must meet the current established threshold
Need help figuring out if you qualify? Please contact MARGENZA Access Support and connect with a support specialist. Call 1-844-MED-MGNX (1-844-633-6469) Monday-Friday 9 AM to 7 PM ET.
Be sure to talk with your doctor about enrolling in the MARGENZA Patient Assistance Program.
To enroll in the MARGENZA Patient Assistance Program, you and your doctor will need to work together to complete the form.
If your doctor wants you to get started, download the form below and then follow the patient instructions.
If you have questions or need help filling out the form, we’re here to help! Call 1-844-MED-MGNX (1-844-633-6469).
Independent foundations
Please call MARGENZA Patient Support at 1-844-MED-MGNX (1-844-633-6469) and we can provide a list of independent/third-party foundations that provide funding for cancer patients with financial hardships.
These independent foundations and charities can provide various forms of assistance to patients who qualify under their rules. These foundations are not associated with MacroGenics.
Although we cannot provide information about a foundation’s funding availability, enrollment process, or eligibility guidelines, this information is available from each organization.
Helpful resources
MARGENZA Patient Brochure
Download for information that can help you or someone you care for understand what to expect from MARGENZA, including treatment benefits, how it works, how it’s given, and more.
Sign up to get updates about MARGENZA
Stay Informed
We're here to help
1-844-MED-MGNX (1-844-633-6469)
MARGENZA Access Support is available Monday–Friday 9 AM to 7 PM ET
Important Safety Information
What is the most important information I should know about MARGENZA?
MARGENZA can cause serious side effects, including:
- Heart problems that may affect your heart’s ability to pump blood. Your doctor will run tests to monitor your heart function before and during treatment with MARGENZA. Based on test results, your doctor may hold or
discontinue treatment with MARGENZA.
- Tell your healthcare provider right away if you get any of the following signs and symptoms: new or worsening shortness of breath, coughing, feeling tired, swelling of the ankles or legs, swelling of the face, irregular heart beat or palpitations, sudden weight gain of more than 5 pounds in 24 hours, dizziness or feeling light-headed, or loss of consciousness.
- Harm to your unborn baby. Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with MARGENZA. Exposure to MARGENZA during pregnancy or within 4 months prior
to conception can result in fetal harm.
- If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with MARGENZA.
- Birth control should be used while receiving MARGENZA and for 4 months after your last dose of MARGENZA.
What are other possible serious side effects of MARGENZA?
Infusion-related reactions. MARGENZA is a medicine that is delivered into a vein through a needle as an infusion. MARGENZA has been associated with infusion-related reactions which can include fever, chills, joint pain, cough, dizziness, tiredness, nausea, vomiting, headache, sweating, fast heart rate, low blood pressure, itching, rash, hives, and shortness of breath. Your healthcare team will monitor you during treatment with MARGENZA and may slow or stop your infusion if you have side effects. You may need to permanently stop MARGENZA if you have a severe infusion reaction.
Before you receive MARGENZA, tell your doctor if you are breastfeeding. It is not known if MARGENZA could pass into breast milk and harm your baby.
What are the most common side effects of MARGENZA in combination with chemotherapy?
The most common side effects with MARGENZA in combination with chemotherapy are fatigue/weakness, nausea, diarrhea, vomiting, constipation, headache, fever, hair loss, abdominal pain, peripheral neuropathy (weakness, numbness, pain, and/or tingling in hands and feet), joint and muscle pain, cough, decreased appetite, shortness of breath, infusion-related reactions, redness/swelling and pain on the palms of the hands and soles of the feet (hand-foot syndrome), and pain in arms and legs.
You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to MacroGenics at (844)-MED-MGNX (844-633-6469).
These are not all the possible side effects of MARGENZA. Your doctor may stop treatment if serious side effects happen. Be sure to contact your healthcare team right away if you have questions or are worried about any side effects.
What does MARGENZA treat?
MARGENZA is a prescription medicine approved for use in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.
Please see full Prescribing Information, including Boxed Warning.
Important Safety Information
What is the most important information I should know about MARGENZA?
MARGENZA can cause serious side effects, including:
- Heart problems that may affect your heart’s ability to pump blood. Your doctor will run tests to monitor your heart function before and during treatment with MARGENZA. Based on test results, your doctor may hold or
discontinue treatment with MARGENZA.
- Tell your healthcare provider right away if you get any of the following signs and symptoms: new or worsening shortness of breath, coughing, feeling tired, swelling of the ankles or legs, swelling of the face, irregular heart beat or palpitations, sudden weight gain of more than 5 pounds in 24 hours, dizziness or feeling light-headed, or loss of consciousness.
- Harm to your unborn baby. Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with MARGENZA. Exposure to MARGENZA during pregnancy or within 4 months prior
to conception can result in fetal harm.
- If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with MARGENZA.
- Birth control should be used while receiving MARGENZA and for 4 months after your last dose of MARGENZA.
What are other possible serious side effects of MARGENZA?
Infusion-related reactions. MARGENZA is a medicine that is delivered into a vein through a needle as an infusion. MARGENZA has been associated with infusion-related reactions which can include fever, chills, joint pain, cough, dizziness, tiredness, nausea, vomiting, headache, sweating, fast heart rate, low blood pressure, itching, rash, hives, and shortness of breath. Your healthcare team will monitor you during treatment with MARGENZA and may slow or stop your infusion if you have side effects. You may need to permanently stop MARGENZA if you have a severe infusion reaction.
Before you receive MARGENZA, tell your doctor if you are breastfeeding. It is not known if MARGENZA could pass into breast milk and harm your baby.
What are the most common side effects of MARGENZA in combination with chemotherapy?
The most common side effects with MARGENZA in combination with chemotherapy are fatigue/weakness, nausea, diarrhea, vomiting, constipation, headache, fever, hair loss, abdominal pain, peripheral neuropathy (weakness, numbness, pain, and/or tingling in hands and feet), joint and muscle pain, cough, decreased appetite, shortness of breath, infusion-related reactions, redness/swelling and pain on the palms of the hands and soles of the feet (hand-foot syndrome), and pain in arms and legs.
You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to MacroGenics at (844)-MED-MGNX (844-633-6469).
These are not all the possible side effects of MARGENZA. Your doctor may stop treatment if serious side effects happen. Be sure to contact your healthcare team right away if you have questions or are worried about any side effects.
What does MARGENZA treat?
MARGENZA is a prescription medicine approved for use in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.
Please see full Prescribing Information, including Boxed Warning.